US researchers have said that women who take aspirin may have a lower risk of dying from cancer and heart disease.
A report that was published in the Journal of the National Cancer Institute looked at data from 22,500 post-menopausal women enrolled in the Iowa Women’s Health Study.
The study found that aspirin users were 13% less likely to die of cancer, 25% less likely to die of heart disease and 18% less likely to die of any cause, compared with women who never used aspirin.
Even though the study did not directly test aspirin’s ability to black cancer, the researcher say that aspirin may provide a modest edge against cancer, cancer deaths and heart disease deaths.